Probiotics Effect in Reducing Behavioral Symptoms and Severity of Autism

Evaluation The effect of Probiotics in Reducing Behavioral Symptoms and Severity of Autism in Children and Adolescents with Autism Spectrum Disorder

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130504013215N2

Enrollment

Registered

2018-05-14

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder. Childhood autism

Interventions

Intervention group: Children with autism disorder are treated with Kidilact probiotics Sache for four weeks. Before entering the study, they filled out the CARS and ATEC questionnaires to measure the

Eligibility

Sex/Gender

All

Age

3 Years to 18 Years

Inclusion criteria

Inclusion criteria: All patients with autism between 3 and 18 years of age

Exclusion criteria

Exclusion criteria: Suffering from chronic infectious diseases Congenital metabolic disorders HIV and Congenital Immunodeficiency Disorder Under treatment with anti-fungal drugs, antibiotics, anti-inflammatory drugs, corticosteroids, anti-diarrheal compounds, chemotherapy

Design outcomes

Primary

Measure	Time frame
Change in symptoms of autism disorder in the CARS questionnaire. Timepoint: When entering the study and 8 weeks after starting treatment. Method of measurement: CARS questionnaire at the beginning and the end of the study.;Change in severity of autism disorder in the ATEC questionnaire. Timepoint: When entering the study and 8 weeks after starting treatment. Method of measurement: ATEC questionnaire at the beginning and the end of the study.	—

Measure

Time frame

Change in symptoms of autism disorder in the CARS questionnaire. Timepoint: When entering the study and 8 weeks after starting treatment. Method of measurement: CARS questionnaire at the beginning and the end of the study.;Change in severity of autism disorder in the ATEC questionnaire. Timepoint: When entering the study and 8 weeks after starting treatment. Method of measurement: ATEC questionnaire at the beginning and the end of the study.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKatayoon Razjouyan

Shahid Beheshti University of Medical Sciences

k_razjouyan@sbmu.ac.ir+98 21 7755 1023

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026